News
Rina-S led to a 50% response rate, including two complete responses, in heavily pretreated advanced endometrial cancer, ...
13h
YourErie on MSNLGL: Paula S. Cousins Ovarian and Endometrial Cancer FoundationThis week’s loving giving local donation goes to an organization that helps women and men in the fight against cancer. It all started with Paula’s story and now it’s ...
8h
Vietnam Investment Review on MSNChina accepts NDA for sintilimab and fruquintinib combo in kidney cancerThe NDA is supported by data from FRUSICA-2, a randomized, open-label, active-controlled registration study evaluating the ...
Hutchmed China and Innovent Biologics announced on Thursday that China’s National Medical Products Administration had accepted a new drug application for a combination therapy using fruquintinib and ...
USA-based subsidiary Vividion Therapeutics has taken over full development and commercialization rights for VVD-214, a ...
A new major study has suggested the risk of getting kidney cancer could be slightly elevated for those who are using the ...
Vividion Therapeutics, Inc. (Vividion), a clinical-stage biopharmaceutical company, and a wholly owned and independently ...
12h
Sportschosun on MSNYum Daeng, divorced from the Grand Library, diagnosed with suspected cancer after uterine extraction, surgery due to daily lifeCreator Yum-daeng confessed that she had undergone uterine extraction surgery.Yum-daeng said, "I haven't heard much lately, ...
The Canadian Press on MSN13h
‘Another universe of pain and suffering’: Patients allege neglectful obstetrical and gynecological care by Toronto doctorMarie-Louise Fitrion says she was asleep in a hospital bed when she woke up to an obstetrician’s hand in her vagina.
7h
Stocktwits on MSNHutchmed Stock Hits Over One-Month High After China Accepts Kidney Cancer NDA Filed With Partner Innovent BiologicsShares of Hutchmed (China) hit their highest levels in over a month after the company announced along with Innovent Biologics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results